Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

More articles from Airway pharmacology and treatment

  • The relationship between eosinophils and reduction in major adverse cardiac events in ETHOS
    Mona Bafadhel, Klaus F Rabe, Dave Singh, Martin Jenkins, Paul Dorinsky, Mehul Patel
    European Respiratory Journal Sep 2021, 58 (suppl 65) RCT208; DOI: 10.1183/13993003.congress-2021.RCT208
  • Characteristics of a real world cohort of Canadians treated with benralizumab
    Stephen G Noorduyn, Mackenzie A Hamilton, Brett Lancaster, Alain Gendron, Lawrence Mbuagbaw, Erika Penz
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3726; DOI: 10.1183/13993003.congress-2021.PA3726
  • The effectiveness of anti-IL5 biologics is comparable in previous-smokers and never-smokers with severe asthma
    Susanne Hansen, Charlotte Ulrik, Ole Hilberg, Anna Von Bülow, Anders Christiansen, Claus R Johnsen, Johannes Schmid, Anne Sofie Bjerrum, Karin Assing, Alexandra Wimmer-Aune, Niels Krogh, Linda Rasmussen, Celeste Porsbjerg
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3742; DOI: 10.1183/13993003.congress-2021.PA3742
  • RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations
    Laura Conejero Hall, Luis Puente Maestu, Myriam Calle Rubio, Walter Girón, Carlos José Alvarez Martínez, María Jesús Buendía García, Joan Serra Batllés, Juan Luis Rodríguez Hermosa, Soledad Alonso Viteri, Julia García De Pedro, Paola Benedetti, Javier De Miguel Díez, José Luis Alvarez-Sala Walther, Julio Hernández Vázquez, Francisco García Río, Carmen Rodríguez Sainz, Cristina Fernández Pérez, Ana Doyle, Raquel Caballero, José Luis Subiza, Miguel Casanovas, Eduardo Fernández-Cruz
    European Respiratory Journal Sep 2021, 58 (suppl 65) RCT207; DOI: 10.1183/13993003.congress-2021.RCT207
  • Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial
    Stefan Andreas, Marco Testa, Laurent Boyer, Guy Brusselle, Wim Janssens, Edward Kerwin, Alberto Papi, Bonavuth Pek, Luis Puente-Maestu, Dinesh Saralaya, Henrik Watz, Tom Ma Wilkinson, Daniela Casula, Gennaro Di Maro, Maria Lattanzi, Luca Moraschini, Sonia Schoonbroodt, Annaelisa Tasciotti, Ashwani K Arora, François Maltais
    European Respiratory Journal Sep 2021, 58 (suppl 65) RCT210; DOI: 10.1183/13993003.congress-2021.RCT210
  • Late Breaking Abstract - Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease - COPD-ST2OP: a phase IIa, placebo-controlled trial
    Ahmed Javid Yousuf, Seid Mohammed, Liesl Carr, Mohammadali Yavari Ramsheh, Koirobi Haldar, Adam K A Wright, Petr Novotny, Sarah Parker, Sarah Glover, Joanne Finch, Kate Hadley, Niamh Quann, Claudia Micieli, Vijay Mistry, Cassandra Brookes, Rachel Hobson, Wadah Ibrahim, Richard Russell, David F Choy, Dorothy Cheung, Michele Grimbaldeston, Catherine John, Michael Steiner, Neil J Greening, Christopher E Brightling
    European Respiratory Journal Sep 2021, 58 (suppl 65) RCT206; DOI: 10.1183/13993003.congress-2021.RCT206
  • Omalizumab exposure patterns in real-life: An 11-year French population-based study of 19,203 patients with severe asthma
    Marc Humbert, Arnaud Bourdin, Antoine Deschildre, Mathieu Molimard, Camille Taille, Driss Kamar, Céline Thonnelier, Audrey Lajoinie, Alexandre Rigault
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3731; DOI: 10.1183/13993003.congress-2021.PA3731
  • Spanish consensus on the characteristics of severe asthmatic patients under biological treatment suitable for at home administration
    Ana Gomez-Bastero Fernandez, Eusebi Chiner, Carolina Cisneros Serrano, Juan Manuel Igea, Elena Villamañán Bueno, Manuel Jorge Rial, Maria José Pla Martí, Valentín López Carrasco, Ana Martínez Meca, Luis Carlos Fernández Lisón, Mª Guadalupe Sánchez-Herrero, Beatriz Velasco-Laorga
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3728; DOI: 10.1183/13993003.congress-2021.PA3728
  • Omalizumab in severe allergic asthma associated with COPD: a multicentric cohort study
    Sophie Pereira, Nathalie Bautin, Juliette Verhille, Philippe Bonniaud, Gilles Devouassoux, Stephanie Fry, Laurent Guilleminault, Naji Khayath, Christophe Leroyer, Cecile Chenivesse, Nathalie Bautin
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3738; DOI: 10.1183/13993003.congress-2021.PA3738
  • Impact of biologic therapy in severe asthma with nasal polyps
    Eduarda M. Tinoco, Ana R. Gigante, Ana L. Fernandes, Bruno Cabrita, Cátia Santa, Inês Sucena, Margarida Silva, Sara Martins, Daniela Machado, Inês Franco, Inês Ladeira, Ivone Pascoal, Ricardo Lima
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3739; DOI: 10.1183/13993003.congress-2021.PA3739

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 113

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society